A Higher-for-Longer Fed Cuts Both Ways for S&P Global

S&P Global faces a mixed impact from higher interest rates: credit rating services could slow as debt issuance weakens, while subscription, index, and private-asset pricing businesses may benefit from volatility and market uncertainty. Analysts still expect EPS growth of 10% in 2026 and 13% in 2027, and the stock trades at about 20x forward earnings with a sub-1% yield and 24% payout ratio. Shares are down more than 20% year-to-date amid rate and AI competition concerns.

Analysis

The market is treating SPGI as a simple duration winner/loser, but the more important issue is mix shift inside the P&L. Elevated rates and choppier capital markets can suppress issuance-driven ratings volume, yet that pain is partially offset by a richer environment for recurring data, indices, and alternative-asset workflows. The stock’s drawdown likely reflects fear that the lower-margin recurring businesses can’t fully offset a slowdown in the high-margin ratings engine; that concern is real, but it also creates a setup where incremental stabilization in debt issuance can lever EPS faster than the market expects.

Second-order effects matter here: higher rates don’t just reduce refinancing; they also push asset allocators toward private credit, secondaries, and illiquid asset valuation services where SPGI is building optionality. That is a longer-dated monetization story, but it can re-rate the multiple if investors start assigning value to a data franchise embedded deeper into private markets infrastructure. Separately, AI risk is being over-discounted if the debate is framed as substitution rather than workflow compression; the subscription products most exposed are the low-friction research layers, while the more defensible segments are those tied to regulatory, benchmark, and embedded-index usage.

The cleaner read is that consensus is extrapolating near-term ratings weakness into a multi-year thesis. If rates plateau rather than rise further, the call option on refinancing activity and M&A issuance reopens quickly, while the recurring businesses keep compounding underneath. In that scenario, current valuation looks more like a de-rating from peak optimism than a structural impairment, and the downside is likely limited unless AI competition meaningfully erodes pricing power in the next 12-18 months.

Key Decisions for Investors

• Initiate a staggered long SPGI position over 4-8 weeks; use weakness driven by rate headlines to build size, with a 12-18 month target on re-acceleration in issuance and private-markets monetization.
• Pair long SPGI vs short a more rate-sensitive capital-markets/issuance proxy over the next 3-6 months; the relative setup improves if refinancing remains muted but data/indices resilience persists.
• Buy SPGI Jan-2027 call spreads to express a delayed normalization thesis; risk/reward is attractive if debt markets thaw in 2026 while premium is capped if rates stay restrictive longer.
• If you already own SPGI, hedge near-term downside with a short-dated put spread around the next FOMC cycle; the main risk window is another 1-2 quarters of weak issuance, not long-term franchise erosion.
• Use a catalyst trigger: add aggressively if management commentary shows any stabilization in debt issuance or private-markets product adoption; that would likely re-rate the stock before reported EPS inflects.